Paige Prostate software receives FDA approval

Create PDF

The FDA evaluated data from a clinical study in which 16 pathologists examined 527 slide images of prostate biopsies (171 cancer, 356 benign) that were digitized using a scanner. The study found that Paige Prostate improved detection of cancer on individual slide images by 7.3 percent on average when compared with pathologists’ unassisted reads for whole slide images of individual biopsies, with no impact on the read of benign slide images.